Concepedia

Cristi R. King

CR

18

Publications

1.9K

Citations

15

H-Index

2004

Active since

Affiliations

Washington University in St. Louis(Current)

Hospital for Special Surgery

University of California, San Francisco

Florida College

University of Alberta

Cristi R. King is an author at Washington University in St. Louis specializing in medicine, pharmacology, and pharmacogenomics.

Top concepts

Publications per year

2004–2022

18

Publications

18

CYP4F2 genetic variant alters required warfarin dose

Michael D. Caldwell, Tarif Awad, Julie A. Johnson et al. · Blood · 2008 · 519 citations · Full text

Pharmacogenetic Assessment of Toxicity and Outcome After Platinum Plus Taxane Chemotherapy in Ovarian Cancer: The Scottish Randomised Trial in Ovarian Cancer

Sharon Marsh, Cristi R. King, Gillian Gifford et al. · Journal of Clinical Oncology · 2007 · 236 citations · Full text

Effect of Genotype-Guided Warfarin Dosing on Clinical Events and Anticoagulation Control Among Patients Undergoing Hip or Knee Arthroplasty

Brian F. Gage, Anne R. Bass, Hannah Lin et al. · JAMA · 2017 · 233 citations · Full text

Pharmacogenetic Predictors of Adverse Events and Response to Chemotherapy in Metastatic Colorectal Cancer: Results From North American Gastrointestinal Intergroup Trial N9741

Howard L. McLeod, Daniel J. Sargent, Sharon Marsh et al. · Journal of Clinical Oncology · 2010 · 215 citations · Full text

ABCG2 Pharmacogenetics

Floris A. de Jong, Sharon Marsh, Ron H.J. Mathijssen et al. · Clinical Cancer Research · 2004 · 206 citations

Rows per page

1–5 of 18